Fem tech startup Inne takes the wraps off a hormone tracker and $8.8M in funding

Berlin-based fem tech startup Inne is coming out of stealth to announce an €8 million (~$8.8M) Series A and give the first glimpse of a hormone-tracking subscription product for fertility-tracking and natural contraception that’s slated for launch in Q1 next year. The Series A is led by led by Blossom Capital, with early Inne backer Monkfish Equity also participating, along with a number of angel investors — including Taavet Hinrikus, co-founder of TransferWise; Tom Stafford, managing partner at DST; and Trivago co-founder Rolf Schromgens. Women’s health apps have been having a tech-fuelled moment in recent years, with the rise of a fem tech category. There are now all sorts of apps for tracking periods and the menstrual cycle, such as …